About Cross Cancer Institute; Clinical Trials
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Cross Cancer Institute; Clinical Trials
During the past decade, Cross Cancer Institute; Clinical Trials conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Cross Cancer Institute; Clinical Trials"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Cross Cancer Institute; Clinical Trials
According to Clinical.Site data, the most researched conditions in "Cross Cancer Institute; Clinical Trials" are
"Breast Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Cross Cancer Institute; Clinical Trials" in a lesser frequency.
Clinical Trials Intervention Types at Cross Cancer Institute; Clinical Trials
Most popular intervention types in "Cross Cancer Institute; Clinical Trials" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab (MPDL3280A), an Engineered Anti-PDL1 Antibody" (1 trials), "Cobimetinib" (1 trials), "Regorafenib" (1 trials), "docetaxel" (1 trials) and "paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cross Cancer Institute; Clinical Trials
The vast majority of trials in "Cross Cancer Institute; Clinical Trials" are
2 trials for "All" genders.
Clinical Trials Status at Cross Cancer Institute; Clinical Trials
Currently, there are NaN active trials in "Cross Cancer Institute; Clinical Trials".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Cross Cancer Institute; Clinical Trials,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cross Cancer Institute; Clinical Trials, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".